Expression of ALCAM in Clinical Colon Cancer and Relationship With Patients' Treatment Responses.

Ziqian Fang,Jimmy Jianyuan Zeng,Yiming Yang,Fiona Ruge,Jane Lane,Rachel Hargest,Wen G Jiang

In vivo (Athens, Greece)（2023）

引用 0|浏览5

暂无评分

摘要

Reduced expression of ALCAM in colon cancer is an indicator of disease progression and a poor prognostic indicator for patient's survival. However, ALCAM can enhance the adhesion ability of cancer cells and render them resistant to chemotherapy drugs.

查看译文

关键词

ALCAM,CD166,clinical outcome,clinical staging,drug response,survival

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要